Faster early tests for flea-borne typhus
Identification of diagnostic biomarkers for flea-borne typhus
['FUNDING_R21'] · UNIVERSITY OF TEXAS MED BR GALVESTON · NIH-11235857
This project searches for specific proteins to enable a quick blood test for people with flea-borne typhus.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS MED BR GALVESTON (nih funded) |
| Locations | 1 site (GALVESTON, UNITED STATES) |
| Trial ID | NIH-11235857 on ClinicalTrials.gov |
What this research studies
You should know that researchers are hunting for bacterial proteins that appear early in the blood during flea-borne typhus. They have already found two promising proteins in lab and animal work that are nearly identical across the bacteria that cause murine and epidemic typhus. The team will use those proteins to build a proof-of-concept antibody-based test to detect infection before antibodies appear. If successful, the test could be developed for use in clinics to help diagnose patients who come in with fever and possible flea or rodent exposure.
Who could benefit from this research
Good fit: People with a recent fever and suspected exposure to fleas or rodents, or anyone with unexplained febrile illness suspected to be typhus, would be the most relevant candidates for sample donation or future testing.
Not a fit: People with unrelated medical conditions, confirmed alternative infections, or past (not current) typhus infections are unlikely to benefit from this diagnostic-focused work.
Why it matters
Potential benefit: A reliable early antigen test could help doctors diagnose typhus sooner, start treatment faster, and reduce complications and healthcare costs.
How similar studies have performed: Existing antibody tests typically work later in illness, so antigen-based early diagnostics are relatively novel, and the investigators' pilot data show promising candidate proteins but a clinical antigen test has not yet been proven.
Where this research is happening
GALVESTON, UNITED STATES
- UNIVERSITY OF TEXAS MED BR GALVESTON — GALVESTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FANG, RONG MEGAN — UNIVERSITY OF TEXAS MED BR GALVESTON
- Study coordinator: FANG, RONG MEGAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.